Concerning the former, serum-neutralizing antibodies targeting the RBD or the entire spike protein are key correlates of protection against symptomatic and severe COVID-19 [72,73,74,75], and are often used to assess vaccine efficacy [76,77,78]. Here, CHMP5 is linked to COVID-19.